A detailed history of Dimensional Fund Advisors LP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 4,024,659 shares of ADMA stock, worth $70.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,024,659
Previous 3,157,960 27.44%
Holding current value
$70.1 Million
Previous $35.3 Million 127.88%
% of portfolio
0.02%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$11.21 - $20.03 $9.72 Million - $17.4 Million
866,699 Added 27.44%
4,024,659 $80.5 Million
Q2 2024

Aug 09, 2024

SELL
$5.98 - $11.18 $2.63 Million - $4.92 Million
-440,076 Reduced 12.23%
3,157,960 $35.3 Million
Q1 2024

May 10, 2024

BUY
$4.4 - $6.74 $470,690 - $721,011
106,975 Added 3.06%
3,598,036 $23.7 Million
Q4 2023

Feb 07, 2024

BUY
$3.08 - $4.52 $1.73 Million - $2.54 Million
561,243 Added 19.16%
3,491,061 $15.8 Million
Q3 2023

Nov 09, 2023

BUY
$3.47 - $4.61 $5.73 Million - $7.61 Million
1,651,433 Added 129.18%
2,929,818 $10.5 Million
Q2 2023

Aug 09, 2023

BUY
$3.12 - $4.22 $3.82 Million - $5.16 Million
1,222,854 Added 2202.11%
1,278,385 $4.72 Million
Q4 2022

Feb 09, 2023

SELL
$2.47 - $3.88 $6,540 - $10,274
-2,648 Reduced 4.55%
55,531 $215,000
Q3 2022

Nov 10, 2022

SELL
$2.03 - $2.86 $11,739 - $16,539
-5,783 Reduced 9.04%
58,179 $141,000
Q2 2022

Aug 12, 2022

BUY
$1.43 - $2.2 $8,994 - $13,838
6,290 Added 10.91%
63,962 $126,000
Q4 2021

Feb 09, 2022

SELL
$1.09 - $1.66 $49,645 - $75,606
-45,546 Reduced 44.13%
57,672 $81,000
Q3 2021

Nov 12, 2021

SELL
$1.13 - $1.65 $40,787 - $59,556
-36,095 Reduced 25.91%
103,218 $117,000
Q2 2021

Aug 12, 2021

SELL
$1.51 - $2.07 $18,724 - $25,667
-12,400 Reduced 8.17%
139,313 $223,000
Q1 2021

May 14, 2021

BUY
$1.67 - $2.95 $253,360 - $447,553
151,713 New
151,713 $267,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.42B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.